COVID-19 Testing, Treatment and Visitation Guidance
Testing Guidance by Source
IHCA Guidance- IHCA Clinical Guidance Summary – Revised 5/8/23
- ICAL Assisted Living Outbreak Checklist (PDF) – updated 7/12/21
- CDC Updated Guidance on Antigen Testing in Long-Term Care Facilities
- CDC Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 – updated 12/29/20
- CDC Interim Guidance for Antigen Testing for SARS-CoV-2 – updated 12/16/20
- CDC Information on use of COVID-19 Antigen Tests in LTC
- QSO-20-38-NH Testing Requirements -Revised 9/23/2022
- AHCA’s Guidance Related to Updated CDC and CMS Requirements – 9/29/22
- CMS Testing FAQ’s & CLIA Guidance During the COVID-19 Emergency
- CMS Laboratory Data Reporting For COVID-19 Testing FAQs
- Medicare Coverage of COVID-19 Testing
Additional Testing Guidance
- Medicare Payment Flowchart – 6/17/22
- Abbott BinaxNOW COVID-19 Ag Card Product Expiry Update – 3/8/21
COVID-19 Visitation Guidance and Resources
Resources for Assisted Living and Skilled Nursing FacilitiesSkilled Nursing Facilities Resources
- IHCA Clinical Guidance Summary – Revised 5/8/23
- QSO-20-39-NH Visitation during COVID-19 – Revised 9/23/2022
- AHCA’s Guidance Related to Updated CDC and CMS Requirements – 9/29/22
Assisted Living and Residential Care Facility Program Resources
- ICAL Clinical Guidance Summary – Updated 6/13/22
- ICAL Assisted Living Outbreak Checklist (PDF) – updated 7/12/21
Treatment Guidance
COVID-19 Treatment Guidance and Information- HHS Therapeutic Definition – 2/1/21
- FDA Bamlanivimab Letter of Authorization (EUA) – 11/10/20
- FDA Bamlanivimab Provider Fact Sheet – 1/28/21
- FDA Casirivimab/imdevimab Letter of Authorization (EUA) – 11/21/20
- FDA Casirivimab/imdevimab Provider Fact Sheet – 12/2020
- IDPH COVID-19 Monoclonal Antibody Provider Request Form – 2/1/21
- IDPH COVID-19 Monoclonal Antibody Therapeutics Information for Providers – 2/1/21